Skip to main content
Clinical Trials/NCT05767138
NCT05767138CompletedNot Applicable

Knowledge, Attitudes, Practices and Willingness to Vaccinate in Preparation for the Introduction of HPV Vaccines in Bamako, Mali

Global Alliance to Immunize Against AIDS Vaccine Foundation0 sites301 target enrollmentStarted: March 2011Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
301
Primary Endpoint
Participants' acceptance of the vaccine

Study Overview

Brief Summary

Although screening for pre-cancerous cervical lesions and human papilloma virus (HPV) vaccination are accepted and effective means to prevent cervical cancer, women in Mali have limited access to these interventions. In addition, cervical cancer prevention by HPV vaccination has been controversial in some settings. To reduce cervical cancer prevalence and increase HPV vaccine uptake, it is important to understand the level of knowledge about cervical cancer screening and practices related to vaccination in at-risk populations. In this study, the level of knowledge about HPV and cervical cancer and attitudes towards vaccination were assessed among 301 participants (male and female, adults and adolescents) in a house-to-house survey in two urban neighborhoods in Bamako, Mali. The survey was combined with a brief educational session on HPV. Prior to the education session, overall knowledge of HPV infection and cervical cancer was very low: only 8% knew that HPV is a sexually transmitted infection (STI). Less than 20% of women had ever consulted a gynecologist and less than 3% had ever had cervical cancer screening. After hearing a description of HPV vaccine, more than 80% would accept HPV vaccination; fathers and husbands were identified as primary decisions makers and local clinics or the home as preferred sites for vaccination. This study provides information on STI knowledge and vaccine acceptance in Bamako, Mali in 2012, prior to the introduction of HPV vaccination.

Study Design

Study Type
Observational
Observational Model
Ecologic Or Community
Time Perspective
Prospective

Eligibility Criteria

Ages
12 Years to — (Child, Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • 12-17 years of age, with guardian consent
  • 18 years or older
  • Male or Female
  • Living in Mèkin-Sikoro and Djikoroni

Exclusion Criteria

  • 12-17 years of age, without guardian consent
  • <12 years of age
  • Living outside Mèkin-Sikoro and Djikoroni

Outcomes

Primary Outcomes

Participants' acceptance of the vaccine

Time Frame: immediately after the intervention

Number of participants willing to be vaccinated against HPV and their vaccination preferences after educational sessions

Secondary Outcomes

  • Knowledge of STIs, HPV, and Cervical Cancer(immediately after the intervention)

Investigators

Sponsor
Global Alliance to Immunize Against AIDS Vaccine Foundation
Sponsor Class
Other
Responsible Party
Sponsor

Similar Trials